{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:36:41Z","timestamp":1784907401034,"version":"3.55.0"},"reference-count":67,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fragile X\u2010associated Tremor\/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder associated with the\n                    <jats:italic>FMR1<\/jats:italic>\n                    premutation. It is currently unknown when, and if, individual premutation carriers will develop FXTAS. Thus, with the aim of identifying biomarkers for early diagnosis, development, and progression of FXTAS, we performed global metabolomic profiling of premutation carriers (PM) who, as part of an ongoing longitudinal study, emerged into two distinct categories: those who developed symptoms of FXTAS (converters, CON) at subsequent visits and those who did not (non\u2010converters, NCON) and we compared to age\u2010matched healthy controls (HC). We assessed CGG repeat allele size by Southern Blot and PCR analysis. Metabolomic profile was obtained by ultra\u2010performance liquid chromatography, accurate mass spectrometer, and an Orbitrap mass analyzer. In this study we found 47 metabolites were significantly dysregulated between HC and the premutation groups (PM). Importantly, we identified 24 metabolites that showed significant changes in expression in the CON as compared to the NCON both at V1 and V2, and 70 metabolites in CON as compared to NCON but only at V2. These findings suggest the potential role of the identified metabolites as biomarkers for early diagnosis and for FXTAS disease progression, respectively. Interestingly, the majority of the identified metabolites were lipids, followed by amino acids. To our knowledge, this the first report of longitudinal metabolic profiling and identification of unique biomarkers of FXTAS. The lipid metabolism and specifically the sub pathways involved in mitochondrial bioenergetics, as observed in other neurodegenerative disorders, are significantly altered in FXTAS.\n                  <\/jats:p>","DOI":"10.1096\/fj.202001880r","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T05:15:20Z","timestamp":1604207720000},"page":"16676-16692","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X\u2010Associated Tremor\/Ataxia Syndrome (FXTAS)"],"prefix":"10.1096","volume":"34","author":[{"given":"Marwa","family":"Zafarullah","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine University of California Davis, School of Medicine Sacramento CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Palczewski","sequence":"additional","affiliation":[{"name":"Metabolon Morrisville NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Rivera","sequence":"additional","affiliation":[{"name":"Center for Mind and Brain University of California Davis Davis CA USA"},{"name":"Department of Psychology University of California Davis Davis CA USA"},{"name":"MIND Institute, University of California Davis Medical Center Sacramento CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Hessl","sequence":"additional","affiliation":[{"name":"MIND Institute, University of California Davis Medical Center Sacramento CA USA"},{"name":"Department of Psychiatry and Behavioral Sciences University of California Davis Medical Center Sacramento CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine University of California Davis, School of Medicine Sacramento CA USA"},{"name":"MIND Institute, University of California Davis Medical Center Sacramento CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/539179a"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.82"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.65"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.4.460"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/gm401"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000091"},{"key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"16293","DOI":"10.1038\/s41598-018-34662-7","article-title":"Metabolic profiling of adherence to diet, physical activity and body size recommendations for cancer prevention","volume":"8","author":"Gu Q","year":"2018","journal-title":"Sci Rep"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-015-0185-x"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.726"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.6b00049"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep43030"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/metabo7030042"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0304-2"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00071"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160585"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2016.00122"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600315R"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy410"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1330-3"},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fnins.2018.00379","article-title":"Middle cerebellar peduncle width\u2014a novel MRI biomarker for FXTAS?","volume":"12","author":"Shelton AL","year":"2018","journal-title":"Front Neurosci"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0112"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-4939-9080-1_15","article-title":"Fragile X\u2010associated tremor\/ataxia syndrome (FXTAS)","volume":"1942","author":"Zafarullah M","year":"2019","journal-title":"Fragile\u2010X Syndrome"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2008.070073"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.136101"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac901536h"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1530509100"},{"key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17797-x","article-title":"Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues","volume":"7","author":"Makrecka\u2010Kuka M","year":"2017","journal-title":"Sci Rep"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.111.969451"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s007020070051"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14098"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2015.03.002"},{"key":"e_1_2_10_33_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-319-11870-3_15","article-title":"The role of the kynurenine pathway in neurodegenerative diseases","author":"Majl\u00e1th Z","year":"2015","journal-title":"Target Broadly Pathogenic Kynurenine Pathway"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.08.005"},{"key":"e_1_2_10_35_1","first-page":"237","article-title":"Ceramide pathway: a novel approach to cancer chemotherapy","volume":"5","author":"Boojar MMA","year":"2018","journal-title":"Egypt J Basic Appl Sci"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.2217\/17460875.1.4.441"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8661-5"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yclnex.2018.05.001"},{"key":"e_1_2_10_39_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/B0-12-443710-9\/00722-5","article-title":"Fatty acid oxidation","volume":"1","author":"Schulz H","year":"2004","journal-title":"Encyclopedia Biol Chem"},{"key":"e_1_2_10_40_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mam.2004.06.001","article-title":"Carnitine: transport and physiological functions in the brain","volume":"25","author":"Nacz K","year":"2004","journal-title":"Mol Aspects Med"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2009.08.004"},{"key":"e_1_2_10_42_1","unstructured":"Critical assessment of the status of biomarkers for Alzheimer\u2019s disease. J Parkinson\u2019s Dis Alzheimer's Dis. 1."},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017299"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191815"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-010-8121-y"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-009-8096-6"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20626"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0305799101"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152012800228661"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-111202"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514561908"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1271-04.2004"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M060061"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00564"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-019-02705-6"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-014-0711-5"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1159\/000466688"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2015.07.007"},{"key":"e_1_2_10_59_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa J","year":"2015","journal-title":"Front Neuroanat"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191670"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijge.2018.03.003"},{"key":"e_1_2_10_62_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1270256","article-title":"Oxidative stress and mitochondrial damage in neurodegenerative diseases: from molecular mechanisms to targeted therapies","volume":"2020","author":"Cenini G","year":"2020","journal-title":"Oxidative Med Cellular Longevity"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2018.01.025"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2010.01.001"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605208103"},{"key":"e_1_2_10_66_1","unstructured":"Journal of Molecular and Genetic Medicine Increased risk for obesity and diabetes with neurodegeneration in developing countries"},{"key":"e_1_2_10_67_1","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.65.8.1114","article-title":"Clinical and neuropathologic Findings in a woman with the FMR1 premutation and multiple sclerosis","volume":"65","author":"Greco CM","year":"2008","journal-title":"Arch Neurol"},{"key":"e_1_2_10_68_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5152\/npa.2015.10011","article-title":"Late onset tremor and ataxia syndrome: FXTAS and its ignored peripheral nervous system findings in diagnostic criteria","volume":"53","author":"Eker A","year":"2016","journal-title":"Noro Psikiyatri Arsivi"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202001880R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.202001880R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202001880R","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:44:04Z","timestamp":1761673444000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.202001880R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1096\/fj.202001880R"],"URL":"https:\/\/doi.org\/10.1096\/fj.202001880r","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"2020-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}